794 related articles for article (PubMed ID: 15914639)
21. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Fang X; Ueno M; Yamashita T; Ikuno Y
Curr Eye Res; 2011 Nov; 36(11):1028-36. PubMed ID: 21999228
[TBL] [Abstract][Full Text] [Related]
22. Strain-dependent differences in oxygen-induced retinopathy in the inbred rat.
van Wijngaarden P; Coster DJ; Brereton HM; Gibbins IL; Williams KA
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1445-52. PubMed ID: 15790914
[TBL] [Abstract][Full Text] [Related]
23. The balance between proteinases and inhibitors in a murine model of proliferative retinopathy.
Majka S; McGuire P; Colombo S; Das A
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):210-5. PubMed ID: 11133870
[TBL] [Abstract][Full Text] [Related]
24. Effects of tetrathiomolybdate in a mouse model of retinal neovascularization.
Elner SG; Elner VM; Yoshida A; Dick RD; Brewer GJ
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):299-303. PubMed ID: 15623788
[TBL] [Abstract][Full Text] [Related]
25. Impact of triamcinolone acetonide on retinal endothelial cells in a retinopathy of prematurity mouse model.
Akkoyun I; Yilmaz G; Oto S; Kahraman B; Haberal N; Akova YA
Acta Ophthalmol Scand; 2007 Nov; 85(7):791-4. PubMed ID: 17488319
[TBL] [Abstract][Full Text] [Related]
26. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
[TBL] [Abstract][Full Text] [Related]
27. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
28. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
29. The role of VEGF and IGF-1 in a hypercarbic oxygen-induced retinopathy rat model of ROP.
Leske DA; Wu J; Fautsch MP; Karger RA; Berdahl JP; Lanier WL; Holmes JM
Mol Vis; 2004 Jan; 10():43-50. PubMed ID: 14758338
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of oxygen-induced retinopathy in RTP801-deficient mice.
Brafman A; Mett I; Shafir M; Gottlieb H; Damari G; Gozlan-Kelner S; Vishnevskia-Dai V; Skaliter R; Einat P; Faerman A; Feinstein E; Shoshani T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3796-805. PubMed ID: 15452091
[TBL] [Abstract][Full Text] [Related]
31. Differences between rat strains in models of retinopathy of prematurity.
Floyd BN; Leske DA; Wren SM; Mookadam M; Fautsch MP; Holmes JM
Mol Vis; 2005 Jul; 11():524-30. PubMed ID: 16052168
[TBL] [Abstract][Full Text] [Related]
32. Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP.
Berkowitz BA; Zhang W
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1925-31. PubMed ID: 10845618
[TBL] [Abstract][Full Text] [Related]
33. Aquaporin-1 independent microvessel proliferation in a neonatal mouse model of oxygen-induced retinopathy.
Ruiz-Ederra J; Verkman AS
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4802-10. PubMed ID: 17898307
[TBL] [Abstract][Full Text] [Related]
34. [Effects of different oxygen inhalation modes on retinal vessels development in neonatal mice].
Wang YH; Chen C; Shi WJ; Xiao HL; Tong BY; Zhou GM
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):129-32. PubMed ID: 16613707
[TBL] [Abstract][Full Text] [Related]
35. Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.
Davies MH; Stempel AJ; Hubert KE; Powers MR
Dev Dyn; 2010 Jun; 239(6):1695-707. PubMed ID: 20503366
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
37. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
38. [Expression of aquaporin 1 in retinal neovascularization: experiment with mice].
Wang X; Xu X; Gu Q
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1569-71. PubMed ID: 18956643
[TBL] [Abstract][Full Text] [Related]
39. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
40. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]